EUVIMEDEUVIMED entdecken
Fallbericht

276 Days of Support by a Micro‐Axial Left Ventricular Assist Device as a Bridge to Heart Transplant

Junichi Shimamura iD, Avi Levine, Stephen Pan iD, Gregg M Lanier iD, Chhaya Aggarwal, Alan Gass, David Spielvogel

Artificial Organs · 2026-11 · 50 (11) · 1668-1671

DOI: 10.1111/aor.70225 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Artificial Organs, online erschienen am 13.08.2026. Verfasst von Junichi Shimamura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Westchester Medical Center, Valhalla, New York, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Heart Failure, Shock, Cardiogenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Impella 5.5 is a surgically implanted micro‐axial left ventricular assist device (LVAD) increasingly utilized for mechanical circulatory support (MCS) in cardiogenic shock. While typically used for acute support up to FDA‐approved 14 days, reports of prolonged utilization remain limited. We present the case of a 69‐year‐old male who presented with severe biventricular failure and cardiogenic shock who was bridged to heart transplantation (HT) utilizing a single Impella 5.5 for a total of 276 days. His prolonged support course was managed through a multidisciplinary approach addressing recurrent ventricular arrhythmias, renal failure, heparin‐induced thrombocytopenia, and device management (suction alarms and purge flow limitations). Following successful HT, the explanted device demonstrated no mechanical injury or thrombus, and pathologic examination revealed no significant device‐related structural heart damage. The patient was discharged without major complications and continued to do well at 5‐month follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart TransplantationHeart FailureShock, CardiogenicHumansMaleAgedBridge TherapyTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Impella 5.5heart failureheart transplantleft ventricular assist device

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Westchester Medical Center, Valhalla, New York, USA.
  • New York Medical College, Valhalla, New York, USA.
  • Department of Cardiology, Westchester Medical Center, Valhalla, New York, USA.

ORCID-Profile: Junichi Shimamura, Stephen Pan, Gregg M Lanier

Zitieren

APA

Shimamura, J., Levine, A., Pan, S., Lanier, G. M., Aggarwal, C., Gass, A., & Spielvogel, D. (2026). 276 Days of Support by a Micro‐Axial Left Ventricular Assist Device as a Bridge to Heart Transplant. Artificial Organs, 50(11), 1668-1671. https://doi.org/10.1111/aor.70225

Vancouver

Shimamura J, Levine A, Pan S, Lanier GM, Aggarwal C, Gass A, et al. 276 Days of Support by a Micro‐Axial Left Ventricular Assist Device as a Bridge to Heart Transplant. Artificial Organs. 2026;50(11):1668-1671. doi:10.1111/aor.70225

BibTeX
@article{Shimamura2026,
  author = {Shimamura, Junichi and Levine, Avi and Pan, Stephen and Lanier, Gregg M and Aggarwal, Chhaya and Gass, Alan and Spielvogel, David},
  title = {276 Days of Support by a Micro‐Axial Left Ventricular Assist Device as a Bridge to Heart Transplant},
  journal = {Artificial Organs},
  year = {2026},
  volume = {50},
  number = {11},
  pages = {1668--1671},
  doi = {10.1111/aor.70225}
}
Kostenlos starten →